3 OUT OF 4 SINUS PAIN SUFFERERS WITH ALLERGIC RHINITIS EXPERIENCED PAIN RELIEF – SEE CLEARUP™ AT THE CES SHOW

3 OUT OF 4 SINUS PAIN SUFFERERS WITH ALLERGIC RHINITIS EXPERIENCED PAIN RELIEF – SEE CLEARUP™ AT THE CES SHOW

January 3, 2019

CES is fast approaching and we’re looking forward to meeting with thousands of technology and medical professionals looking for the latest healthcare offerings.

For the first time, Tivic Health will be demonstrating the newly FDA cleared product ClearUP Sinus Pain Relief to the public at Sands Expo, Eureka Park, Health Section, Booth #53355.

ClearUP is a groundbreaking product for sinus pain for allergic rhinitis sufferers that was successfully tested with consumers in a double-blinded. Randomized Control Trial at a top-tier US science research center. The results were presented this fall at the American Rhinologic Society’s (ARS) Annual Meeting in Atlanta. The study included patients with Allergic rhinitis, Chronic Rhinosinusitis and other sinus pain causes. Overall results were:

  • 3 out of 4 who used ClearUP experienced a reduction in sinus pain
  • Patients treated with Tivic Health’s microcurrent ClearUP device experienced an average pain reduction of 30 percent
  • 82 percent preferred ClearUP Sinus Pain Relief device to their current sinus treatment(s).

In May 2018, recent third-party market research with 600 sinus sufferers has also revealed that sinus sufferers tend to use pills (75%) and prescription nose sprays (60%). However, 91% of them are concerned about taking too much medicine and 66% concerned about side effects.  ClearUP is an ideal option because it is drug-free, has no known side effects and is reusable for anytime, anywhere treatments.

Tivic Health is part of the emerging Bioelectronics industry. In fact, this fall the World Economic Forum named bioelectronics or “electroceuticals” as one of the top 10 disruptive technologies poised to change medical treatment.

We look forward to seeing you in Las Vegas!

Stay Informed!

Join our mailing list for Tivic news, offers and more